Addus HomeCare (ADUS) Files Form 144 for 25,000-Share Sale

Rhea-AI Filing Summary

Addus HomeCare Corp. (ADUS) submitted a Form 144 disclosing a proposed sale of 25,000 common shares through Morgan Stanley Smith Barney LLC, scheduled for 08/20/2025. The filing shows the shares were acquired and paid for on 08/20/2025 via a stock option exercise with cash payment. The aggregate market value of the shares at filing is $2,873,862.50 and the company reports 18,407,239 shares outstanding. The filer reports no sales of the issuer’s securities in the past three months and includes the standard Rule 144 representation regarding possession of material nonpublic information.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 disclosure of an insider sale following option exercise; paperwork aligns with standard compliance expectations.

The Form 144 documents a proposed sale by a person who exercised options and intends to sell 25,000 shares through Morgan Stanley Smith Barney LLC on 08/20/2025. The filing provides required details: acquisition method (stock option exercise), payment method (cash), aggregate market value ($2,873,862.50), and shares outstanding (18,407,239). The absence of reported sales in the prior three months simplifies aggregation calculations. From a compliance standpoint, the notice contains the necessary representations about material nonpublic information and lists a broker, satisfying typical Rule 144 disclosure elements.

Equity Capital Markets Analyst

TL;DR: Transaction size is small relative to shares outstanding; likely limited market impact but transparency is positive.

The proposed sale of 25,000 shares equals approximately 0.14% of the reported 18,407,239 shares outstanding, and the aggregate market value is stated as $2,873,862.50. The filer indicates acquisition and payment occurred on the same date via option exercise, suggesting this is an immediate monetization by an insider or option holder. Given the small proportion of outstanding stock and no other sales in the prior three months, the transaction appears unlikely to materially affect trading or the company’s capitalization.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	2873862.50	18407239	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2025	Stock Option Exercise	Issuer			25000	08/20/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)